Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
DNL151 / Denali Therap, Biogen
Structure of LRRK2 in Parkinson’s disease and model for microtubule ...
DNL151 « New Drug Approvals
C2h4cl2 Lewis Structure In 6 Steps With Images
RCSB PDB - 8E81: Structure of LRRK2-CHK1 10-pt. mutant complex with ...
Structure of LRRK1 and mechanisms of autoinhibition and activation - PMC
RCSB PDB - 8SMC: Cryo-EM structure of LRRK2 bound with type-I inhibitor ...
Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s ...
Science Translational Medicine：帕金森病治疗的一大步：LRRK2抑制剂临床试验评估-MedSci.cn
Structure-Based Virtual Screening and De Novo Design to Identify ...
The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2 ...
Inhibition of Parkinson’s disease–related LRRK2 by type I and type II ...
Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich ...
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung ...
ScienceofParkinsons on Twitter: "The summary slides of the lysosomal ...
LRRK2 in Parkinson's disease: upstream regulation and therapeutic ...
LRRK2/NUAK1/TYK2-IN-1 | | TargetMol
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for ...
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2 ...
Frontiers | Development of mutation-selective LRRK2 kinase inhibitors ...
The luminance of a lighthouse – The Science of Parkinson's
LRRK2抑制剂——帕金森病的明日之星 文章来源：“ 凯莱英 药闻”微信公众号帕金森病（Parkinson′s disease，PD）是第二 ...
LRRK2-targeted treatments including LRRK2 inhibitors and antisense ...
A step forward for LRRK2 inhibitors in Parkinson’s disease | Science ...
Document
dnli-20191231
LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease
The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 ...
Breakthrough Ideas for Parkinson’s Disease Treatment - Creative Diagnostics
Design of leucine-rich repeat kinase 2 (LRRK2) inhibitors using a ...
Capturing Differences in the Regulation of LRRK2 Dynamics and ...
Leucine‐rich repeat kinase 2 disturbs mitochondrial dynamics via ...
Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine ...
Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors ...
Oral Parkinson's Therapy Safely Lowers LRRK2 Activity in Phase 1 Trials
LRRK2 and idiopathic Parkinson’s disease: Trends in Neurosciences
Leucine-rich repeat kinase 2 (LRRK2) therapeutics. | Download ...
Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in ...
figure10.jpg
LRRK2 Inhibitor | LRRK2 Inhibitor Review
Structural biology of Parkinson’s disease-associated leucine-rich ...
Ten Years and Counting: Moving Leucine-Rich Repeat Kinase 2 Inhibitors ...
Table 1 from Discovery of potent and selective 5-azaindazole inhibitors ...
Closing the structure-to-function gap for LRRK2: Trends in Biochemical ...
LRRK2 Kinase Inhibitors as Possible Therapy for Parkinson’s Disease and ...
LRRK2 GTP binding inhibitors for treatment of parkinson's disease and ...
Stabilization and inhibition of LRRK2's kinase by type-I and type-II ...
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a ...
BIIB122 – The Science of Parkinson's
“compound 24”
LRRK2 complex modulates Dll1 turnover in the endosomal pathway. (A ...
Development of a leucine-rich repeat-containing protein 15-targeted ...
The 2D chemical structures of ATP competitive LRRK2 inhibitors ...
D151
LRRK2 and Parkinson's disease: from genetics to targeted therapy ...
GNE-0877 (DNL201) | LRRK2 inhibitor | CAS 1374828-69-9 | Selleck
Phosphorylation of s15 by Pathogenic LRRK2 Variants and Block by ...
默沙东LRRK2抑制剂的优化-MedSci.cn
Chemical structures of representative selective LRRK2 inhibitors ...
Department of Biochemistry | Emory School of Medicine
NSC-370875, D-15413-药物合成数据库
Efficacy and pharmacodynamic properties of the LRRK2 kinase inhibitor ...
Frontiers | Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics
LRRK2-IN-15 | LRRK2 Inhibitor | MedChemExpress
LRRK2抑制剂——帕金森病的明日之星|抑制剂|帕金森病|LRRK2|蛋白|磷酸化|-健康界
达尔文内酯，一种新型的二萜骨架，可抑制南极海绵 状树突藻（Dendrilla membranosa）的 耐甲氧西林 金黄色葡萄球菌 生物膜 ...
LRRK2-phosphorylated Rab10 sequesters Myosin Va with RILPL2 during ...
Type II kinase inhibitors that target Parkinson’s disease–associated ...
Design of an LRRK2 inhibitor-desensitized mutant (A) Structural model ...
Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by ...
Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways ...
Structural Basis of Wnt Signaling Inhibition by Dickkopf Binding to ...
DNL-151(DNL-151) - 药物靶点：LRRK2_在研适应症：帕金森病_专利_临床_研发
Our Parkinson's Place: First Parkinson’s Patient Dosed in Early Trial ...
Structure-activity relationships among DNA ligase inhibitors ...
Target familial PD genes that contribute to a-synuclein toxicity -LRRK2 ...
Deal: Biogen to co-develop and co-commercialize LRRK2 inhibitors with ...
Nanobodies as allosteric modulators of Parkinson’s disease–associated ...
Devimistat(CPI-613)
LRRK2-IN-1 inhibits DCLK1 kinase activity. An in vitro kinase assay was ...
Parkinsonism & Related Disorders
Rab10 and pRab10 immunofluorescence and confocal microscopy images in ...
Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration ...
2 Parkinson's Trials to Test Oral BIIB122/DNL151 in Slowing Progression
Nature Reviews Drug Discovery on Twitter: "LRRK2-targeted Parkinson ...
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the ...
Characterization of a selective inhibitor of the Parkinson’s disease ...
RN341 | LRRK2 Inhibitor | MedChemExpress
Rationale for LRRK2 inhibition in sporadic Parkinson’s disease and the ...
LRRK2-targeted treatments including LRRK2 inihibitors and antisense ...
Characterization of ROCK inhibitors as LRRK2 inhibitors (A) The ...
LRRK2 kinase activity regulates Parkinson’s disease-relevant lipids at ...
Frontiers | Advances in RIPK1 kinase inhibitors
用于 PD 治疗的小分子 LRRK2 抑制剂：当前成就和未来展望,European Journal of Medicinal ...
